Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells

被引:103
作者
de Graaff, PAA
de Jong, EC
van Capel, TM
van Dijk, MEA
Roholl, PJM
Boes, J
Luytjes, W
Kimpen, JLL
van Bleek, GM
机构
[1] Univ Med Ctr, Dept Pediat, Wilhelmina Childrens Hosp, NL-3584 EA Utrecht, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1012 WX Amsterdam, Netherlands
[3] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands
[4] Netherlands Vaccine Inst, Bilthoven, Netherlands
关键词
D O I
10.4049/jimmunol.175.9.5904
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in children, the elderly, and immune-compromised individuals. CD4 and CD8 T cells play a crucial role in the elimination of RSV from the infected lung, but T cell memory is not sufficient to completely prevent reinfections. The nature of the adaptive immune response depends on innate immune reactions initiated after interaction of invading pathogens with host APCs. For respiratory pathogens myeloid dendritic cell (DC) precursors that are located underneath the epithelial cell layer lining the airways may play a crucial role in primary activation of T cells and regulating their functional potential. In this study, we investigated the role of human monocyte-derived DC in RSV infection. We showed that monocyte-derived DC can be productively infected, which results in maturation of the DC judged by the up-regulation of CD80, CD83, CD86, and HLA class II molecules. However, RSV infection of DC caused impaired CD4 T cell activation characterized by a lower T cell proliferation and ablation of cytokine production in activated T cells. The suppressive effect was caused by an as yet unidentified soluble factor produced by RSV-infected DC.
引用
收藏
页码:5904 / 5911
页数:8
相关论文
共 42 条
[1]   Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells [J].
Baize, S ;
Kaplon, J ;
Faure, C ;
Pannetier, D ;
Georges-Courbot, MC ;
Deubel, V .
JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :2861-2869
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-γ in naive T cells [J].
Bartz, H ;
Türkel, Ö ;
Hoffjan, S ;
Rothoeft, T ;
Gonschorek, A ;
Schauer, U .
IMMUNOLOGY, 2003, 109 (01) :49-57
[5]   Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry [J].
Bendelja, K ;
Gagro, A ;
Bace, A ;
Lokar-Kolbas, R ;
Krsulovic-Hresic, V ;
Drazenovic, V ;
Mlinaric-Galinovic, G ;
Rabatic, S .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :332-338
[6]   Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis [J].
Bont, L ;
Heijnen, CJ ;
Kavelaars, A ;
van Aalderen, WMC ;
Brus, F ;
Draaisma, JTM ;
Geelen, SM ;
van Vught, HJ ;
Kimpen, JLL .
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (01) :144-149
[7]  
Brandenburg AH, 2000, J MED VIROL, V62, P267, DOI 10.1002/1096-9071(200010)62:2&lt
[8]  
267::AID-JMV20&gt
[9]  
3.0.CO
[10]  
2-8